WHO ICTRP trial
An open-label randomised observer-blind study to evaluate 24-hour intragastric…
EUCTR2006-006726-26-SE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-006726-26-SE |
|---|---|
| Public title | An open-label randomised observer-blind study to evaluate 24-hour intragastric pH profile at day 1 and day 14 during treatment with a fixed combination of a histamine type 2 receptor antagonist and a proton pump inhibitor |
| Scientific title | An open-label randomised observer-blind study to evaluate 24-hour intragastric pH profile at day 1 and day 14 during treatment with a fixed combination of a histamine type 2 receptor antagonist and a proton pump inhibitor |
| Primary sponsor | Orexo AB |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Sweden |
| Conditions | Frequent heartburn |
| Interventions | Product Code: OX17 Pharmaceutical Form: Capsule* INN or Proposed INN: FAMOTIDINE CAS Number: 76824356 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 10- INN or Proposed INN: OMEPRAZOLE CAS Number… |
| Registration date | Jan 30, 2007 |
| Target size | 60 |
| Secondary IDs | 101266 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: